Utah Senate Bill 190 was introduced on February 9, 2022. This bill proposes to expand the medical use of cannabis in the state of Utah. But may more notable, it would also ban delta-8 THC products from being sold in the state of Utah. This comes at a time when delta-8 products are surging in popularity across the country.
Among other things, Senate Bill 190 also has provisions that would allow midwives to recommend cannabis, create new labeling requirements for products, and would allow medical cannabis to be a treatment option for patients who are deemed to be terminally ill.
When it comes to THC the bill would revise existing definitions meaning that delta-8 THC would count towards the 0.3% limit that is currently imposed on hemp products.
When talking about THC in cannabis most of us are referring to delta-9 THC. This is the naturally occurring THC molecule in cannabis that is psychoactive. Delta-8 THC is different in that it only occurs naturally in cannabis in very small amounts. The products you see in stores like delta-8 gummies require a chemical process to create the delta-8 molecule.
Under Senate Bill 190, any THC in cannabis would count toward the overall THC limit of 0.3%. This would actually be a huge change for the cannabis industry in the state of Utah.
The bill was introduced by Senate Majority Leader Evan Vickers (R-Cedar City). In Senator Vickers’ words “Somebody’s always pushing the envelope. That’s kind of what’s happened. That envelope is being pushed so we’re trying to rein it back in.”
Like most things in life, it’s all about how you look at the matter. You are probably not surprised to know that there are very different views on the subject within the state. Some people support the banning of delta-8 THC while others don’t.
Utah’s Cannabinoid Product Board is Against Delta-8
The Cannabinoid Product Board is a legitimate state agency in the state of Utah. Some of the main functions are to review scientific and medical research. Based on their research they formulate guidelines for medical providers who are recommending cannabinoid products to patients.
It is important to note that the Cannabinoid Product Board does not have any authority when it comes to actually making policies in the state. It is still interesting that the board unanimously voted to stand against delta-8 THC.
What Could This Mean on a National Level?
Even though delta-8 THC products have been surging in the U.S. we could soon see a shift. The Hemp Advancement Act was introduced to the United States Congress in early February. If passed it changes the language in the 2018 Farm Bill that only limited delta-9 THC. If legislation such as the Hemp Advancement Act were to pass through Congress it would have implications on a national level. It could quickly bring an end to the booming sales of delta-8 CBD products across the United States.
It’s important to note that none of these changes would influence CBD. CBD is a non-intoxicating cannabinoid and the Utah Senate Bill does not take aim specifically at CBD.